awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34823216-392BC625-EFA1-425D-8F51-7946D6D408E7
Q34823216-392BC625-EFA1-425D-8F51-7946D6D408E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34823216-392BC625-EFA1-425D-8F51-7946D6D408E7
Utilization of bone densitometry for prediction and administration of bisphosphonates to prevent osteoporosis in patients with prostate cancer without bone metastases receiving antiandrogen therapy.
P2860
Q34823216-392BC625-EFA1-425D-8F51-7946D6D408E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34823216-392BC625-EFA1-425D-8F51-7946D6D408E7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8bf95c7fd0decca35053f3ca318102b1b5fe1b10
P2860
Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer.